Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 7/20 | 1.00 |
| ▸ | SHBG | P04278 | 7/20 | 0.69 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.69 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | THRB | P10828 | 1/20 | 0.69 |
| ▸ | PGR | P06401 | 5/20 | 0.55 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.48 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.48 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.48 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25863609 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL1255845 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL29880093 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL5188310 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL24102494 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL14342101 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL24103284 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL5026430 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL24103286 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 | |
| SCHEMBL199806 | 1.00 | AR (1.00) | ARSHBGSERPINA6SLC22A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 999 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3441089-B1 | TREATMENT METHODS USING ADENOVIRUS | VASCULAR BIOGENICS LTD (IL) | 2022-12-14 | — | — | EP | claimed |
| EP-3191114-B1 | OCCIDIOFUNGIN FORMULATIONS AND USES THEREOF | UNIV MISSISSIPPI STATE (US) | 2021-03-03 | — | — | EP | claimed |
| EP-2908865-B1 | ADENOVIRUS EXPRESSING A FAS-CHIMERA AND USE THEREOF IN CANCER TREATMENT METHODS | VASCULAR BIOGENICS LTD (IL) | 2018-10-03 | — | — | EP | claimed |
| EP-2923703-B1 | TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS | NANTBIO INC (US) | 2018-09-19 | — | — | EP | claimed |
| EP-3368081-A1 | TREATMENT OF CANCER WITH COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES | IO Therapeutics, Inc. (US) | 2018-09-05 | — | — | EP | claimed |
| EP-3124481-B1 | ANDROGEN RECEPTOR MODULATORS AND USES THEREOF | ARAGON PHARMACEUTICALS INC (US) | 2018-03-28 | — | — | EP | claimed |
| US-20170348321-A1 | Wafer Comprising Steroid Hormones | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2017-12-07 | — | — | US | claimed |
| US-9763960-B2 | Wafer comprising steroid hormones | LTS LOHMANN THERAPLE-SYSTEME AG (DE) | 2017-09-19 | — | — | US | claimed |
| WO-2017075612-A1 | TREATMENT OF CANCER WITH COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES | Io Therapeutics, Inc. (US) | 2017-05-04 | — | — | WO | claimed |
| US-9364488-B2 | Myelin regeneration with androgens | THE POPULATION COUNCIL, INC. (US) | 2016-06-14 | — | — | US | claimed |
| WO-2003079961-A2 | METHOD FOR PRODUCING 7$G(A)-METHYL STEROIDS | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-10-02 | — | — | WO | claimed |
| WO-2003068314-A1 | PULMONARY ADMINISTRATION OF 6-ALPHA-ALKYLATED TESTOSTERONE DERIVATIVES FOR ANDROGEN REPLACEMENT THERAPY | PANTARHEI BIOSCIENCE B.V. (NL) | 2003-08-21 | — | — | WO | claimed |
| US-20030096739-A1 | Nuclear receptor-mediated introduction of a PNA into cell nuclei | POPULATION COUNCIL, INC., THE | 2003-05-22 | — | — | US | claimed |
| WO-2002083186-A1 | NUCLEAR RECEPTOR-MEDIATED INTRODUCTION OF A PNA INTO CELL NUCLEI | THE POPULATION COUNCIL, INC. (US) | 2002-10-24 | — | — | WO | claimed |
| EP-0970704-B1 | Silicone core long term androgen delivery implant | POPULATION COUNCIL INC (US) | 2002-09-11 | — | — | EP | claimed |
| US-20020012694-A1 | TRANSDERMAL ADMINISTRATION OF MENT | POPULATION COUNCIL, INC., THE, A CORP. OF NY | 2002-01-31 | — | — | US | claimed |
| US-6117441-A | Silicone core long term androgen delivery implant | THE POPULATION COUNCIL, INC. (US) | 2000-09-12 | — | — | US | claimed |
| EP-0941039-A1 | TRANSDERMAL ADMINISTRATION OF MENT | THE POPULATION COUNCIL, INC. (US) | 1999-09-15 | — | — | EP | claimed |
| WO-1999013812-A1 | TRANSDERMAL ADMINISTRATION OF MENT | THE POPULATION COUNCIL, INC. (US) | 1999-03-25 | — | — | WO | claimed |
| US-5342834-A | Administering testosterone derivatives | THE POPULATION COUNCIL, INC. (US) | 1994-08-30 | — | — | US | claimed |